Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bristol’s Bold Projections Grow Bolder As Confidence In R&D Programs Rises
New And Existing Blockbusters Expected To Fill Future Revenue Gaps
Nov 17 2021
•
By
Mandy Jackson
Bristol expects low- to mid-single-digit compound annual revenue growth through 2025 • Source: Alamy
More from New Products
More from Scrip